NF2 and neoplasm: We also demonstrated that the application of specific neutralizing antibodies to block the function of TGF‐β could partly reduce MDSC‐mediated inhibition of T cells, indicating that elucidation of such NF2‐associated tumor‐initiated suppressive mechanisms could be helpful for designing effective immunotherapeutic protocols and likely bring new possible therapeutic interventions for NF2 patients.